Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 23;24(1):285.
doi: 10.1186/s12876-024-03339-z.

RARB associated with MSI, affects progression and prognosis of gastric cancer

Xufan Cai #  1 , Wenfa Lin #  1   2 , Fang Wu  3 , Guangyuan Song  4 , Zhenyuan Qian  5 , Yu Wang  6
Affiliations

RARB associated with MSI, affects progression and prognosis of gastric cancer

Xufan Cai et al. BMC Gastroenterol. .

Abstract

Microsatellite instability (MSI) has been widely acknowledged as an important factor regulating tumor intrinsic biological behavior and affecting the survival of gastric cancer patients. Here, we firstly identified the RARB as a gene associated with MSI gastric cancer. RARB was downregulated in human gastric cancer tissues compared to paired paracancerous tissues, Knockdown of RARB accelerated the proliferation, invasion and migration of cancer cells in vitro. Mechanismly, RARB knockdown promoted epithelial-mesenchymal transition (EMT) process of gastric cancer. However, RARBLow patients exhibited better survival compared to RARBHigh patients. Further study revealed that RARB expression was inversely correlated with MSI status and immune infiltrates in vivo. Thus, RARB may be a potential target for the treatment of gastric cancer.

Keywords: Gastric cancer; MSI; RARB; Tumor immune microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
RARB was identified as an important MSI associated gene (A, B): Heatmap of mantis score and sensors score; (C, D): VENN diagram shows 24 downregulated genes and 1 upregulated gene associated with MSI; (E, F,G): GO pathway analysis in terms of biological process, cellular component and molecular function; (H): Activity of Candidate Genes in Cancer-Related Pathways. (I): RARB and AR were the main genes participating in the cancer pathway
Fig. 2
Fig. 2
The Clinical relevance of RARB. (A, B, C, D): Relationship between the expression of RARB and MMR system-related proteins; E: Relationship between RARB expression and MSI status in gastric cancer patients; (F, G, H, I, J, K, L, M, N): Relationship between RARB expression and clinical characteristics of RARB. *, P < 0.05;**, P < 0.01;***, P < 0.001
Fig. 3
Fig. 3
Knockdown of RARB accelerated the proliferation, invasion and migration of cancer cells in vitro. A: Representative immunohistochemical images of RARB expression in normal gastric tissues and gastric cancer tissues; B: The mRNA level of RARB in gastric cancer cells detected by qRT-PCR; (C, D): The expression level of RARB after knockdown by siRNA in two gastric cancer cells, MKN-7 and HGC-27; (E, F): The CCK-8 assay revealed the growth trend of gastric cancer cells after RARB knockdown; (G): The effect of RARB knockdown on the proliferation of gastric cancer cells via colony formation assay; (H): The cell migration and invasion capacity of gastric cancer cells detected by transwell assay after RARB knockdown. *,P < 0.05;**,P < 0.01;***,P < 0.001.
Fig. 4
Fig. 4
RARB knockdown promoted epithelial-mesenchymal transition (EMT) process of gastric cancer. (A, B, C): GESA analysis of relationship between RARB and advanced cancer process, lymphatic vessels invasion, and EMT; (D): Effect of knockdown of RARB on EMT makers’ expression in gastric cancer cells by Western blot. *, P < 0.05;**, P < 0.01;***, P < 0.001
Fig. 5
Fig. 5
RARB controls different transcriptional programs in gastric cancer. A: DEGs histogram; B: DEGs volcano plot; C: DEGs heatmap; D: GO enrichment analysis; E: KEGG enrichment analysis
Fig. 6
Fig. 6
RARB expression is inversely correlated with survival of gastric cancer patients. A: Kaplan-Meier analysis of disease free survival for gastric cancer patients with high (n = 192) and low (n = 192) RARB expression. B: Kaplan-Meier analysis of overall survival for gastric cancer patients with high (n = 192) and low (n = 192) RARB expression; Representative immunohistochemical images of CD3, CD8 and CD68 expression in RARB RARBHigh and RARBLow gastric cancer tissues
See this image and copyright information in PMC

References

    1. Lordick F, Shitara K, Janjigian YY. New agents on the horizon in gastric cancer[J]. Annals Oncology: Official J Eur Soc Med Oncol. 2017;28(8):1767–75.10.1093/annonc/mdx051 - DOI - PubMed
    1. Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer[J]. Lancet (London England). 2020;396(10251):635–48. 10.1016/S0140-6736(20)31288-5 - DOI - PubMed
    1. Sever R, Glass CK. Signaling by Nuclear Receptors[J]. Cold Spring Harb Perspect Biol. 2013;5(3):a016709–016709. 10.1101/cshperspect.a016709 - DOI - PMC - PubMed
    1. Altucci L, Leibowitz MD, Ogilvie KM, et al. RAR and RXR modulation in cancer and metabolic disease[J]. Nat Rev Drug Discovery. 2007;6(10):793–810. 10.1038/nrd2397 - DOI - PubMed
    1. Noy N. Between death and survival: retinoic acid in regulation of Apoptosis[J]. Annu Rev Nutr. 2010;30(1):201–17. 10.1146/annurev.nutr.28.061807.155509 - DOI - PubMed

Substances

LinkOut - more resources